Lara E. Coelho

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Raphael J. Landovitz, Deborah Donnell, Meredith E. Clement et al. · New England Journal of Medicine · 2021 · 853 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +16

Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors

David R Bakal, Lara E. Coelho, Paula M. Luz et al. · Journal of Antimicrobial Chemotherapy · 2018 · 190 citations · Full text

Public Health, Health Sciences, Infectious Disease Control +14

Impact of COVID-19 Pandemic on Sexual Minority Populations in Brazil: An Analysis of Social/Racial Disparities in Maintaining Social Distancing and a Description of Sexual Behavior

Thiago S. Torres, Brenda Hoagland, Daniel R. B. Bezerra et al. · AIDS and Behavior · 2020 · 138 citations · Full text

Public Health, Health Policy, Population Health Sciences +17

Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

Mark A. Marzinke, Beatriz Grinsztejn, Jessica M. Fogel et al. · The Journal of Infectious Diseases · 2021 · 130 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +17

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Nanina Anderegg, Klea Panayidou, Yao Abo et al. · Clinical Infectious Diseases · 2017 · 122 citations · Full text

Public Health, Infectious Disease Control, Population Health Sciences +17